Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 3, Issue 5, Page 9 (May 2007)


View previous. 11 of 30 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (79 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

The Promise of rFVIIa Dimmed in Phase III Trial

MICHELE G. SULLIVAN (Mid-Atlantic Bureau)

BOSTON — Despite high hopes for success, a phase III trial of the first medical therapy for intracerebral hemorrhage showed that the drug was no better than placebo in improving rates of death or disability 3 months after the bleed occurred.

PII: S1553-3212(07)70153-X

doi:10.1016/S1553-3212(07)70153-X


View previous. 11 of 30 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.